The largest database of trusted experimental protocols

15 protocols using mushroom tyrosinase ec 1.14.18.1

1

In Vitro Tyrosinase Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mushroom tyrosinase (EC 1.14.18.1) (Sigma Chemical Co.) was used for in vitro bioevaluation as described previously with some modifications [40 (link)–41 (link)]. Briefly, 140μL of phosphate buffer (20mM, pH 6.8), 20μL of mushroom tyrosinase (30U/mL) and 20μL of the inhibitor solution were placed in the wells of a 96-well micro plate. After pre-incubation for 10 min at room temperature, 20μL of L-DOPA (3,4-dihydroxyphenylalanine) (0.85mM) was added and the plate was further incubated at 25°C for 20min. Subsequently the absorbance of dopachrome was measured at 492nm using a micro plate reader (OPTIMax, Tunable). Kojic acid was used as a reference inhibitor and for negative tyrosinase inhibitor phosphate buffer was used instead of the inhibitor solution. The extent of inhibition by the synthesized carvacrol derivatives 4a-f and 6a-d was expressed as the percentage of concentration necessary to achieve 50% inhibition (IC50). Each concentration was analyzed in three independent experiments run in triplicate. The IC50 values were determined by the data analysis and graphing software Origin 8.6, 64-bit.
+ Open protocol
+ Expand
2

Characterizing Mushroom Tyrosinase Kinetics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mushroom tyrosinase (EC 1.14.18.1) was purchased from Sigma-Aldrich. Tyrosinase inhibition assays were conducted as described in [52 (link)] with slight modifications. First, in order to characterize the Michaelis-Menten parameters of the enzyme kinetics, 100 μl of a mushroom tyrosinase solution (25 U) in sodium phosphate buffer (50 mM, pH 6.5) were pipetted in each well of a flat-bottom microtiter plate (Nunc 167008). Two-fold dilutions of L-Dopa, from 4.8 to 0.075 mM (final concentrations) were mixed (100 μl) with the enzyme solution. The enzymatic reaction was followed by measuring the absorbance at 475 nm every 30 s over 15 min, with shaking (150 rpm) between measurements. Temperature was kept constant at 30ºC. The values of KM and vmax under these conditions were obtained from Lineweaver-Burk plots. For tyrosinase inhibition assays, each well of the microtiter plate was filled with 100 μl of a mushroom tyrosinase solution and the appropriate amount of the test substance dissolved in DMSO. The compounds were pre-incubated with the enzyme at 30ºC for 10 min. Subsequently, the enzymatic reaction was triggered by addition of 100 μl of L-Dopa (1.2 mM test concentration). Formation of dopachrome was followed by measuring the absorbance at 475 nm as described above. Kojic acid (Sigma-Aldrich) was used as positive control.
+ Open protocol
+ Expand
3

Tyrosinase Inhibition Assay with L-Dopa

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mushroom tyrosinase (EC 1.14.18.1) (Sigma Chemical Co.) was assayed using L-Dopa as the substrate as reported in our previous studies with some modifications30 (link)–32 (link). The enzyme diphenolase activity was monitored spectrophotometrically by observing dopachrome formation at 490 nm. All the test samples were first dissolved in DMSO at 10 mM and diluted to the required concentrations. Initially, in a 96-well microplate, 10 µl of test samples were added to 160 µl of 50 mM phosphate buffer (pH = 6.8) and then 10 µl tyrosinase (500 U mL−1) was added. After the mixture was pre-incubated at 28 °C for 20 min, 20 µl of L-Dopa solution (7 mM) was added to the mixture. After 10 min incubation absorbance of samples was measured. DMSO without test compounds was used as the control, and kojic acid was used as a positive control. Each assay was conducted as three separate replicates. The inhibitory activity of the tested compounds was expressed as the concentration that inhibited 50% of the enzyme activity (IC50). The percentage inhibition ratio was calculated according to the following equation: Inhibition%=100Abscontrol-Abscompound/Abscontrol
+ Open protocol
+ Expand
4

Comprehensive Melanogenic Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
n-Hexane, chloroform, ethyl acetate (EtOAc), n-butanol, ethanol, and methanol were obtained from OCI (SEL, KR). Folin–Ciocalteu reagent (for total phenolics), 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2′-Azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) (ABTS), dimethyl sulfoxide-d6 (DMSO, exclusive solvent for NMR), mushroom tyrosinase (EC 1.14.18.1), and ascorbic acid were obtained from Sigma Aldrich (St. Louis, MO, USA). All reagents used were of analytical grade. Phospho-CREB (p-CREB), phospho-PKA (p-PKA), AMPK, p-AKT, AKT, p-mTOR, mTOR, Becline, and LC3B were purchased from Cell Signaling (Danvers, MA, USA). Antibodies against tyrosinase (TYR), TRP-1, TRP-2, microphthalmia-associated transcription factor (MITF), CREB, PKA, α-melanocyte-stimulating hormone (α-MSH), and β-actin were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Horseradish-peroxidase-conjugated anti-mouse, anti-goat, and anti-rabbit antibodies were purchased from Invitrogen (Carlsbad, CA, USA).
+ Open protocol
+ Expand
5

Tyrosinase Inhibition Kinetic Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mushroom tyrosinase (EC 1.14.18.1) was purchased from Sigma Chemical Co. (St. Louis, MO, USA). Tyrosinase inhibition assays and kinetic analysis were performed as previously described.[19] For experimental details see Supporting Information.
+ Open protocol
+ Expand
6

Mushroom Tyrosinase Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mushroom tyrosinase (EC 1.14.18.1) (Sigma Chemical Co., ST. Louis, MO) was used for in vitro bioassays as described previously with some modifications39 (link),40 (link). Briefly, 140 µL of phosphate buffer (20 mM, pH 6.8), 20 µL of mushroom tyrosinase (30 U/mL) and 20 µL of the inhibitor solution were placed in the wells of a 96-well micro plate. After pre-incubation for 10 min at room temperature, 20 µL of L-DOPA (3,4-dihydroxyphenylalanine) (0.85 mM) was added and the plate was further incubated at 25 °C for 20 min. Subsequently the absorbance of dopachrome was measured at 492 nm using a micro plate reader (OPTI Max, Tunable). Kojic acid was used as a reference inhibitor and for negative tyrosinase inhibitor phosphate buffer was used instead of the inhibitor solution. The extent of inhibition by the test compounds was expressed as the percentage of concentration necessary to achieve 50% inhibition (IC50). Each concentration was analysed in three independent experiments run in triplicate. The IC50 values were determined by the data analysis and graphing software Origin 8.6, 64-bit.
+ Open protocol
+ Expand
7

Tyrosinase Inhibition Bioassay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mushroom tyrosinase (EC 1.14.18.1) used for the bioassay was purchased from Sigma Chemical Co.. In vitro tyrosinase assay was assessed according to Kubo and Kinst-Hori18 (link) with little modification. Briefly, In a 96 well plate system, mushroom tyrosinase was performed in triplicates through a mixture preparation. The mixture was prepared by adding 40 µl of phosphate buffer, 100 µl of the sample (KA-PS) and the positive control (KA). Further 20 µl of tyrosinase enzyme (1,100 units/ml:0.516 mg/ml phosphate buffer 0.1 M), L-dopa (5 mM) was added in the 40 µl volume and the mixture was incubated for ten minutes at 37℃. The optical density of dopachrome formation was measured using the spectrophotometric enzyme-linked immunosorbent assay reader at an optical density of 475 nm (The inhibitory percentage of tyrosinase was calculated as follows: Inhibition=[(ΔAcontrol-ΔAsample)/ΔAcontrol]×100). The IC50, defined as the concentration of KA-peptides required to inhibit tyrosinase activity by 50%, was determined for each sample. All experiments were performed at least three times, with similar consequences.
+ Open protocol
+ Expand
8

Tyrosinase Inhibition Assay Using Mushroom Enzyme

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mushroom tyrosinase (EC 1.14.18.1) was purchased from Sigma Chemical Co. (St. Louis, MO, USA). Tyrosinase inhibition was assayed as previously described [14]. Briefly, aliquots (0.05 mL) of test compound at various concentrations (0.10–50 μM) were firstly mixed with 0.5 mL of L‐DOPA solution (1.25 mM), 0.9 mL of phosphate buffer (0.05 M, pH 6.8). The reaction mixture was preincubated at 25 °C for 10 min. Subsequently, 0.05 mL of an aqueous solution of mushroom tyrosinase (333 U/mL) was added to this mixture. Afterward, the linear increase in absorbance (Abs) was immediately recorded up to 5 minutes at 475 nm. The inhibitory activity was expressed as inhibition percentage respect to control sample. The concentrations leading to 50 % activity loss (IC50) were also calculated by interpolation of the dose‐response curves. Kojic acid [5‐hydroxy‐2‐(hydroxymethyl)‐4H‐pyran‐4‐one], a fungal secondary metabolite used as skin whitening agent, was employed as a positive standard (8–32 μM). A spectrophotometer (Shimadzu UV‐1601) was used for absorbance measurements.
+ Open protocol
+ Expand
9

Mushroom Tyrosinase Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mushroom tyrosinase (EC 1.14.18.1) (Sigma Chemical Co.) was assayed as explained previously with slight modifications applying L-DOPA as substrate [54 (link)]. In spectrophotometric experiments, enzyme activity was monitored by observing dopachrome formation at 475 nm. The stock solutions of test compounds 3ak and kojic acid were first dissolved in DMSO at 40 mM and then diluted with phosphate buffer (pH = 6.8) to the required concentrations. First, 10 µL of mushroom tyrosinase (0.5 mg mL−1) was mixed with 160 µL of phosphate buffer (50 mM, pH = 6.8) and then 10 µL of the test sample in 96-well microplates was added. After the mixture was pre-incubated at 28 °C for 20 min, 20 µL of L-DOPA solution (0.5 mM) was added to the phosphate buffer and dopachrome formation was monitored at 475 nm for 10 min. DMSO without test compounds was used as the control, and kojic acid was used as the positive control. Each assay was conducted as three separate replicates. The final concentration of DMSO in the test solution was less than 2.0%. The percent inhibition ratio was calculated according to the following equation: Inhibition%=100×Abscontrol-Abscompound/Abscontrol.
The inhibitory activity of the tested compounds was expressed as the concentration that inhibited 50% of the enzyme activity (IC50).
+ Open protocol
+ Expand
10

Tyrosinase Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mushroom tyrosinase (EC 1.14.18.1) (Sigma-Aldrich Chemical Co., St. Louis, MO, USA) was used for the tyrosinase assay, with either l-DOPA or l-tyrosine as a substrate. In spectrophotometric experiments, enzyme activity was taken as the initial velocity (Vi) monitored by observing dopachrome formation at 475 nm with a UV spectrophotometer at 30 °C. All samples were dissolved in ethanol at 10 mM. First, 200 μL of a 2.7 mM l-tyrosine or 5.4 mM l-DOPA aqueous solution was mixed with 2687 μL of 0.25 M phosphate buffer (pH 6.8). Next, 100 μL of the sample solution and 13 μL of the same phosphate buffer solution containing mushroom tyrosinase (144 units) were added to the mixture. The inhibitor concentration that gave a 50% loss of activity (IC50) was obtained by fitting the experimental data to the logistic curve.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!